These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 24504814)
1. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity. Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S Mod Rheumatol; 2012 Sep; 22(5):668-75. PubMed ID: 22160844 [TBL] [Abstract][Full Text] [Related]
3. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis. Lei L; He ZY; Zhao C; Sun XJ; Zhong XN Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680 [TBL] [Abstract][Full Text] [Related]
4. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
5. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342 [TBL] [Abstract][Full Text] [Related]
6. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis. Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895 [TBL] [Abstract][Full Text] [Related]
7. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267 [TBL] [Abstract][Full Text] [Related]
9. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis. Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424 [TBL] [Abstract][Full Text] [Related]
10. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis. Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295 [TBL] [Abstract][Full Text] [Related]
11. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2). Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680 [TBL] [Abstract][Full Text] [Related]
12. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032 [TBL] [Abstract][Full Text] [Related]
13. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis. Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144 [TBL] [Abstract][Full Text] [Related]
14. The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis. Yoshizaki A; Yanaba K; Ogawa A; Iwata Y; Ogawa F; Takenaka M; Shimizu K; Asano Y; Kadono T; Sato S Arthritis Rheum; 2011 Oct; 63(10):3086-97. PubMed ID: 21618208 [TBL] [Abstract][Full Text] [Related]
15. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Brissett M; Veraldi KL; Pilewski JM; Medsger TA; Feghali-Bostwick CA Arthritis Rheum; 2012 Jan; 64(1):272-80. PubMed ID: 21898349 [TBL] [Abstract][Full Text] [Related]
17. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis. Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239 [TBL] [Abstract][Full Text] [Related]
18. Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells. Hsu YA; Chang CY; Lan JL; Li JP; Lin HJ; Chen CS; Wan L; Liu FT J Biomed Sci; 2020 Jan; 27(1):24. PubMed ID: 31937306 [TBL] [Abstract][Full Text] [Related]
19. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Takahashi T; Asano Y; Ichimura Y; Toyama T; Taniguchi T; Noda S; Akamata K; Tada Y; Sugaya M; Kadono T; Sato S Arthritis Rheumatol; 2015 Jan; 67(1):254-65. PubMed ID: 25302613 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]